INKON Life Technology Co., Ltd.

30
Sell
  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE100000XF6
CNY
12.53
0.14 (1.13%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationCash Flow
INKON Life Technology Co., Ltd. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
No of Months
12
12
12
12
12
12
Profit Before Tax
151.00
149.00
131.00
-565.00
-324.00
201.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
50.00
8.00
-26.00
11.00
2.00
-166.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
340.00
259.00
190.00
160.00
137.00
87.00
Cash Flow from Investing Activities
-672.00
-442.00
-272.00
-409.00
218.00
-211.00
Cash Flow from Financing Activities
167.00
938.00
119.00
20.00
-210.00
497.00
Net Cash Inflow / Outflow
-164.00
755.00
36.00
-228.00
144.00
373.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
0.00
0.00
0.00
0.00
0.00
0.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in CNY Million
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of INKON Life Technology Co., Ltd.
Figures in Million
Markets Mojo
No Consolidated Results Declared by Selected Peer
Cash Flow - Snapshot (Consolidated) - Dec'25
stock-summary

YoY Growth in year ended Dec 2025 is 31.47% vs 36.44% in Dec 2024

Dec'25
Dec'24
Change(%)
Cash Flow from Operating Activities
340.83
259.25
31.47%